Literature DB >> 10486917

Novel triazolo[4,3-a]quinazolinone and bis-triazolo[4,3-a:4,3'-c]quinazolines: synthesis and antitoxoplasmosis effect.

A A el-Tombary1, K A Ismail, O M Aboulwafa, A M Omar, M Z el-Azzouni, S T el-Mansoury.   

Abstract

Several quinazoline derivatives containing substituted thiosemicarbazido and S-methylisothiosemicarbazido groups at the 2-position and at both the 2- and 4-positions have been synthesized. Treatment of the S-methylthiosemicarbazides with morpholine or diethylamine did not give the corresponding guanidines. Instead, they underwent cyclodesulfurization into the condensed ring systems, [1,2,4]triazolo[4,3-a]quinazolinones and bis-[1,2,4]triazolo[4,3-a:4'.3'-c]quinazolines. Evaluation of the products for antitoxoplasmosis effect by studying the ultrastructure morphology of the organisms using scanning electron microscopy (SEM) indicated their efficacy in causing structural deformity of Toxoplasma gondii. Such a deformity plays an important role in obstructing the entry of the organisms into host cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486917     DOI: 10.1016/s0014-827x(99)00038-5

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  3 in total

1.  2-Eth-oxy-5-methylbis[1,2,4]triazolo[1,5-a:4',3'-c]quinazoline.

Authors:  Rashad Al-Salahi; Detlef Geffken; Ahmed Bari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-12-14

2.  Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain.

Authors:  Aref Teimouri; Sanaz Jafarpour Azami; Hossein Keshavarz; Fariba Esmaeili; Rasoul Alimi; Sara Ayazian Mavi; Saeedeh Shojaee
Journal:  Int J Nanomedicine       Date:  2018-03-08

3.  Synthesis, tautomeric structure and antimicrobial activity of 3-arylhydrazono-4-phenyl-[1,2,4]-triazepino[2,3-a]quinazoline-2,7(1H)-diones.

Authors:  Thoraya Abdel Reheem Farghaly; Mastoura Mohamed Edrees; Mosselhi Abdelnabi Mosselhi
Journal:  Molecules       Date:  2012-07-13       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.